Antares Pharma Reports Second Quarter 2019 Operating and Financial Results
Record Quarterly Revenue of $28.4 Million - Double Second Quarter 2018 Revenue
The Company Increases Full Year 2019 Revenue Guidance to a Range of $100.0 to $110.0 Million
EWING, N.J., Aug. 06, 2019 (GLOBE NEWSWIRE) -- Antares Pharma, Inc. (NASDAQ: ATRS) ("the Company") today reported operating and financial results for the second quarter ended June 30, 2019. The Company reported revenue of $28.4 million and a net loss per share of $0.01 for the quarter ended June 30, 2019. The...